SYNLAB AG: SYNLAB Medical Congress: making healthcare future-proof with advanced diagnostics 10.05.2022 / 08:32 The issuer is solely responsible for the content of this announcement. Hosting its 2022 ...

SYNLAB AG (“SYNLAB” or “the Group”, FSE: SYAB), the leader in medical diagnostic services and specialty testing in Europe, today announced its unaudited Q1 2024 results. The Group reports strong ...

Synlab Italia has suspended all its medical diagnostic and testing services after a ransomware attack forced its IT systems to be taken offline. Part of the Synlab group that is present in 30 ...

SYNLAB reports a strong start to the fiscal year 2022 12.05.2022 / 07:00 The issuer is solely responsible for the content of this announcement. SYNLAB, the leader in medical diagnostic services and ...

SYNLAB AG: SYNLAB invests in new, cutting-edge laboratory in Munich and further expands its leading position in the region (news with additional features) The issuer is solely responsible for the ...

MCLEAN, Va.--(BUSINESS WIRE)--Mars, Incorporated (“Mars”) today announced that it has completed its previously announced acquisition of the assets of SYNLAB Vet from SYNLAB Group (FSE: SYAB). SYNLAB ...

German laboratory services group Synlab said on Wednesday it planned to float on the stock market, offering investors exposure to a coronavirus testing boom and the consolidation of Europe's ...

Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The ...